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A B S T R A C T
Whilst the ‘Principles of clinical use of antibiotics’ was released by the Ministry of Health of the People’s
Republic of China in 2004, limited research has been conducted to evaluate the quality of antibiotic use
in real-world practice. In this study, we sought to examine antimicrobial prescribing patterns in a large
tertiary hospital in Shanghai, China. De-identiﬁed outpatient and emergency department pharmacy records
containing antimicrobials were extracted from the hospital electronic health records system. Antimi-
crobial prescribing patterns and out-of-pocket medical costs for antimicrobials were evaluated by patient
demographics and the primary diagnosis. Antimicrobial prescriptions stratiﬁed by patient age group (<5,
5–17, 18–49, 50–64 and ≥65 years) were also examined. A total of 363 642 antimicrobial prescriptions
in 2014 were obtained, corresponding to 197 781 unique patients. Approximately 18% of antimicrobial-
containing prescriptions were for acute upper respiratory infection and bronchitis, 15% for fever or cough,
5% for gastritis and duodenitis and non-infective gastroenteritis and colitis, and 7% for other diagnoses
without clear indications of bacterial infection. Cephalosporins were the most frequently prescribed an-
tibiotic class (55%). Age-speciﬁc antimicrobial prescriptions showed different patterns between children
and adults. A total of US$4.6 million were spent as out-of-pocket costs on antimicrobials in 2014, and
the median antimicrobial cost per prescription was $9. Unnecessary antibiotic use is still common in real-
world clinical practice and remains a public health challenge. Antibiotic-related medical expenditure also
presents an important economic burden.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Antibiotic resistance is ‘a global health crisis’ and is one of the
‘greatest challenges for public health’ [World Health Organization
(WHO)]. Overuse of antibiotics is the primary risk factor for antibi-
otic resistance and can cause adverse drug events [1]. In China,
antibiotic resistance due to overuse of antibiotics has been a persis-
tent public health problem [2,3]. Several studies have reported that
a high percentage (>50%) of outpatient visits result in prescription
of antibiotics [4–6]. In 2004, the ‘Principles of clinical use of antibiot-
ics’ was released by the Ministry of Health of the People’s Republic
of China to guide appropriate antibiotic use [7]; and in 2012, a formal
legislation was established to regulate the rational use of antibiot-
ics in all clinical settings [8]. Reform of the healthcare system in China
has also helped to eliminate ﬁnancial incentives associated with an-
tibiotic prescriptions for hospitals and physicians [9]. During 2012–
2014, a nationwide campaign of rational antibiotic use was
implemented at secondary and tertiary hospitals to establish clini-
cal infrastructure for antibiotic management, to reinforce regulation
and clinical guidelines for rational antibiotic use, to set speciﬁc targets
for antibiotic prescriptions, and to develop surveillance systems to
monitor and audit antibiotic prescriptions [10,11].
Following this national antibiotic use campaign, a few studies have
shown signiﬁcant reductions in antibiotic use in China, indicated by
decreasing antibiotic prescribing rates and deﬁned daily doses (DDDs)
as well as lower patient costs for antibiotics across different health-
care settings in China [12–14]. Whilst these studies demonstrate
important achievements of the national campaign, knowledge gaps
still exist regarding the quality of antibiotic use. Therefore, more re-
search is needed to better evaluate the effect of the national antibiotic
campaign on reducing irrational use of antibiotics.
Studies using a random sample of primary care facilities indi-
cated that between 2009 and 2011, <40% of outpatient antibiotic
prescriptions were appropriate and about 80% of patients with a
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cold, pharyngitis or acute bronchitis were prescribed antibiotics [5,6].
However, given the large volume of the patient populations, it is
not feasible to review all of the medical or pharmacy records to de-
termine irrational use of antibiotics at secondary or tertiary public
hospitals. Considering the establishment of electronic data systems
was a key component in the national antibiotic use campaign in order
to collect health records, these large available data sets offer a unique
opportunity to monitor antibiotic prescriptions. In this study, we
sought to explore routinely collected electronic health record (EHR)
data to examine the real-world antimicrobial prescribing patterns
in a large tertiary hospital in Shanghai, China.
2. Methods and materials
2.1. Setting and patient population
Shanghai Tenth People’s Hospital of Tongji University (Shang-
hai, China) is a level 3A hospital, which is the highest-level hospital
in China with the most advanced medical technologies providing
outpatient and emergency care and inpatient services to nearly
900 000 people living in the catchment area. This 1860-bed hos-
pital employs ca. 4200 staff and is responsible for delivering high-
quality medical care. The hospital also provides a number of
specialised care and comprehensive programmes, including nursing
specialty, stomatology, a traditional Chinese medicine (TCM) centre
for cardio-cerebrovascular diseases and a visual restoration centre.
Because of the unique features of the healthcare system in China,
Shanghai Tenth People’s Hospital serves as a primary care facility
through the outpatient departments that include internal medi-
cine, paediatrics, surgery, otolaryngology, dentistry, infectious
diseases, dermatology, obstetrics and gynaecology, and TCM.
The Department of Internal Medicine is the largest outpatient
department consisting of eight divisions: general internal medi-
cine; asthma and pulmonary; cardiology; endocrinology;
gastroenterology; haematology; nephrology; and neurology. The
emergency departments, which cover services that are provided by
the outpatient departments except infectious diseases and derma-
tology, are open 24 h a day to serve patients with urgent medical
needs. In Shanghai, healthcare costs for most urban residents are
covered by medical insurance (employer-based or private) or gov-
ernment programmes; patients can choose their healthcare providers
without referrals or can walk in to any clinics during regular working
hours. The pertinent out-of-pocket medical costs (physician charges,
laboratory tests or medication costs) are almost the same across dif-
ferent healthcare facilities. Thus, a large number of patients seek
primary care at Shanghai Tenth People’s Hospital. However, because
there are more physicians available at the outpatient depart-
ments, in general patients prefer going to the outpatient departments
unless they have urgent or life-threatening conditions. In 2014 there
were 2 176 653 outpatient visits, and visits to the Department of
Internal Medicine accounted for 46% of the total outpatient visits
(994 661), but the total emergency department visits were only
367 119.
In response to the national antibiotic use campaign, Shanghai
Tenth People’s Hospital launched a special antimicrobial manage-
ment committee that was composed of infectious diseases
physicians, infectious diseases pharmacists and infection control spe-
cialists to categorise and oversee antibiotics use. Prescriptions of
antibiotics that are classiﬁed as ‘restricted use’ require approval by
the committee, and restricted antibiotics are primarily used in in-
patient care. Clinical pharmacists also evaluate a random sample
of outpatient prescriptions on a monthly basis to identify possible
irrational use of antibiotics and to provide feedback to the antimi-
crobial management committee and the leadership. Meanwhile, in
Shanghai a strict policy has been implemented to restrict proﬁts for
drug sales at public hospitals, especially tertiary hospitals. The
incomes both for hospitals and physicians rely on government ﬁ-
nancial support and medical proﬁts resulting from the volume of
work or the effort spent on treating patients. Therefore, at Shang-
hai Tenth People’s Hospital physicians do not gain economic
incentives for prescribing antimicrobials. A computerised network
is implemented across the clinical departments to manage routine
operations of the hospital and to maintain EHRs, providing a foun-
dation for evaluating the real-world antimicrobial prescription
patterns.
2.2. Data sources
The de-identiﬁed pharmacy records of hospital-based outpa-
tient departments and emergency departments (EDs) indicating any
antimicrobial(s) prescribed during 1 January 2014 to 31 Decem-
ber 2014 were extracted from the hospital EHR system. The ED
records were exclusively for outpatients. According to theWHO clas-
siﬁcation scheme [15], antimicrobial prescriptions were identiﬁed
using the China National Drug Code directory, generic names or
brand names. We focused on systemic antimicrobials and did not
include topical antimicrobial prescriptions such as ophthalmic oint-
ments and skin creams in this study. Each antimicrobial-containing
prescription record included a pseudo patient identiﬁer (ID), a pseudo
prescription ID, the visit date, patient age and sex, the WHO Inter-
national Statistical Classiﬁcation of Diseases and Related Health
Problems, 10th Revision (ICD-10) code [16] for the primary diag-
nosis based on the patient’s chief complaint, clinical department,
detailed antimicrobial prescription (antimicrobial drug code, dosage,
route and package), and the out-of-pocket medical costs for anti-
microbials and for all medications per prescription (converted from
Chinese Yuan into 2014 US$ based on an exchange rate of 6.40 Yuan
to US$1). One patient can have multiple antimicrobials prescribed
during one visit or multiple visits during the study period.
2.3. Data analysis
Antimicrobials were classiﬁed as cephalosporins, macrolides/
lincosamides, quinolones, penicillins, aminoglycosides, tetracyclines,
imidazoles and other classes [7]. Within each class, the top three
most commonly prescribed drugs were checked. Patients’ primary
diagnoses were grouped into 10 diagnostic categories according to
the ICD-10 code [16].
Consistent with the antimicrobial drug evaluation method, an-
timicrobial prescribing patternswere examined by patient age groups
and sex, date of visit, clinical department and the primary diagno-
sis [17]. Antimicrobial prescriptions were also stratiﬁed by patients’
age group (<5, 5–17, 18–49, 50–64 and ≥65 years). Data were
analysed using SAS v.9.3 (SAS Inc., Cary, NC). This study was ap-
proved by the Institutional Research Ethics Review Board of Shanghai
Tenth People’s Hospital of Tongji University.
3. Results
A total of 363 642 antimicrobial-containing prescriptions in 2014,
corresponding to 197 781 unique patients and 429 650 antimicro-
bials, were obtained from the EHR system. There were 219 648
outpatient prescriptions and 143 994 ED prescriptions. The major-
ity of prescriptions were for broad-spectrum antibiotics, and
prescriptions for other antimicrobials, including antifungals, antivirals
or antimycobacterials, were rare (<5% of the total study records).
Among the 197 781 patients, 46% had multiple antimicrobial pre-
scriptions (Fig. 1). Seasonal variation was observed across all age
groups, indicating more antimicrobial prescriptions occurring in
winter months (January and December 2014) (Fig. 2a). Interest-
ingly, a second peak of antimicrobial prescriptions was seen during
July–August 2014 in adults aged 18–49 years. The distribution of
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monthly prescribed antibiotics (Fig. 2b) also supported this sea-
sonal variation, indicating more cephalosporins, macrolides/
lincosamides and quinolones prescribed in January or December.
As more patients seek care at the outpatient departments, we
compared whether there were noticeable differences in antimicro-
bial prescriptions between outpatient and ED visits (Table 1a).
Internal medicine and paediatric departments were the top two clin-
ical departments both in outpatient and ED settings where patients
received antimicrobial prescriptions. Diseases of the respiratory
systemwere the most common primary diagnosis in antimicrobial-
containing prescriptions (41.0%), followed by symptoms, signs and
abnormal clinical and laboratory ﬁndings (22.7%) and diseases of
106 119, 54%
28 467, 14%
36 921, 19%
26 274, 
13%
Single visit-Single antimicrobial
Single visit-Multiple antimicrobials
Multiple visits-Single antimicrobial/visit
Multiple visits-Multiple 
antimicrobials/visit
Fig. 1. Distribution of single and multiple antimicrobial prescriptions in 197 781 patients seeking ambulatory care in a large hospital in Shanghai, China, 2014.
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Fig. 2. Number of antimicrobial prescriptions in each calendar month in 2014 stratiﬁed by (a) age groups and (b) antibiotics classes.
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Table 1
(a) Characteristics of patients receiving antimicrobial prescriptions by setting in a large tertiary hospital in Shanghai, China, 2014. (b) Antimicrobial prescribing patterns by
setting in a large tertiary hospital in Shanghai, China, 2014.
(a)
Characteristic Total [N (%)] Outpatient [n (%)] ED [n (%)]
Total antimicrobial-containing prescriptions 363 642 219 648 143 994
Patient age
<5 years 67 256 (18.5) 39 100 (17.8) 28 156 (19.5)
5–17 years 49 474 (13.6) 27 326 (12.4) 22 148 (15.4)
18–49 years 119 776 (32.9) 74 776 (34.0) 45 000 (31.2)
50–64 years 72 651 (20.0) 48 257 (22.0) 24 394 (16.9)
≥65 years 54 485 (15.0) 30 189 (13.7) 24 296 (16.9)
Patient sex
Female 186 794 (51.4) 114 165 (52.0) 72 629 (50.4)
Male 176 848 (48.6) 105 483 (48.0) 71 365 (49.6)
Clinical department
Internal medicine 122 949 (33.8) 59 810 (27.2) 63 139 (43.8)
Paediatrics 109 329 (30.1) 62 569 (28.5) 46 760 (32.5)
Surgery 43 702 (12.0) 25 337 (11.5) 18 365 (12.8)
Otolaryngology 31 651 (8.7) 22 774 (10.4) 8 877 (6.2)
Infectious diseases 21 871 (6.0) 21 871 (10.0) –
Dentistry 17 231 (4.7) 13 770 (6.3) 3 461 (2.4)
Dermatology 8 132 (2.2) 8 132 (3.7) –
Obstetrics and gynaecology 3 733 (1.0) 3 199 (1.5) 534 (0.4)
Other 5 044 (1.4) 2 186 (1.0) 2 858 (2.0)
ICD-10 diagnosis category
Diseases of the respiratory system 149 223 (41.0) 90 564 (41.2) 58 659 (40.7)
Acute upper respiratory infection 39 610 24 514 15 096
Bronchitis, not speciﬁed as acute or chronic 24 610 18 408 6 202
Other respiratory disorders 21 911 9 453 12 458
Pneumonia, unspeciﬁed organism 18 794 9 479 9 315
Symptoms, signs and abnormal clinical and laboratory ﬁndings 82 462 (22.7) 34 143 (15.5) 48 319 (33.6)
Fever of other and unknown origin 35 734 15 180 20 554
Cough 19 860 11 332 8 528
Abdominal and pelvic pain 14 536 2 366 12 170
Diseases of the digestive system 45 802 (12.6) 35 364 (16.1) 10 438 (7.2)
Gastritis and duodenitis 10 272 7 662 2 610
Non-infective gastroenteritis and colitis 9 535 8 142 1 393
Diseases of pulp and periapical tissues 3 478 2 859 619
Diseases of the genitourinary system 25 875 (7.1) 19 287 (8.8) 6 588 (4.6)
Other disorders of urinary system 15 596 11 457 4 139
Inﬂammatory diseases of prostate 1 436 1 384 52
Calculus of kidney and ureter 1 338 673 665
Infectious and parasitic diseases 21 279 (5.9) 16 190 (7.4) 5 089 (3.5)
Bacterial infection of unspeciﬁed site 5 252 4 472 780
Infectious gastroenteritis and colitis, unspeciﬁed 4 575 1 885 2 690
Zoster 3 528 3 512 16
Diseases of the ear and mastoid process 7 606 (2.1) 5 546 (2.5) 2 060 (1.4)
Suppurative and unspeciﬁed otitis media 3 571 2 510 1 061
Otitis externa 2 358 1 684 674
Injury, poisoning and other consequences of external causes 7 341 (2.0) 2 354 (1.1) 4 987 (3.5)
Injury of unspeciﬁed body region 2 991 583 2 408
Diseases of the circulatory system 7 020 (1.9) 3 257 (1.5) 3 763 (2.6)
Non-speciﬁc lymphadenitis 1 608 1 254 354
Primary hypertension 1 414 956 458
Diseases of the skin and subcutaneous tissue 6 044 (1.7) 5 509 (2.5) 535 (0.4)
Other local infections of skin and subcutaneous tissue 1 706 1 534 172
All other diagnoses 10 990 (3.0) 7 434 (3.4) 3 556 (2.5)
Dorsalgia 1 177 457 720
(b)
Characteristic Total [N (%)] Outpatient [n (%)] ED [n (%)]
Total prescribed antimicrobials 429 650 257 388 172 262
Antimicrobial class
Cephalosporins 235 089 (54.7) 120 930 (47.0) 114 159 (66.3)
Cefuroxime 78 506 30 079 48 427
Cefaclor 73 050 42 954 30 096
Cefprozil 32 325 18 113 14 212
Macrolides/lincosamides 77 706 (18.1) 54 585 (21.2) 23 121 (13.4)
Azithromycin 26 242 18 061 8 181
Clindamycin 25 726 15 661 10 065
Midecamycin 11 199 6 359 4 840
Quinolones 66 942 (15.6) 40 420 (15.7) 26 522 (15.4)
Levoﬂoxacin 60 157 34 294 25 863
Norﬂoxacin 5 739 5 080 659
Moxiﬂoxacin 1 043 1 043 0
(continued on next page)
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the digestive system (12.6%). Noteworthy, 17.7% (64 220) of
antimicrobial-containing prescriptions were for acute upper respi-
ratory infection (AURI) or bronchitis, 15.3% (55 594) were for fever
or cough, 5.4% (19 807) were for gastritis and duodenitis and non-
infective gastroenteritis and colitis, and 7% were for other diagnoses
without clear indications of bacterial infections (e.g. injury, dis-
eases of the circulatory system). The prescription patterns by the
primary diagnosis differed between the outpatient and ED set-
tings: diseases of the digestive system accounted for a higher
proportion of antimicrobial-containing prescriptions in the outpa-
tient departments (16.1% vs. 7.2%; P < 0.0001); whilst in the ED the
proportion was higher for a primary diagnosis of symptoms, signs
and abnormal clinical and laboratory ﬁndings (33.6% vs. 15.5%;
P < 0.0001).
There were 429 650 antimicrobials prescribed in 2014 (Table 1b).
Consistent with the primary diagnosis, cephalosporins were themost
frequently prescribed antibiotics across all diagnosis categories
(54.7%), followed bymacrolides/lincosamides (18.1%) and quinolones
(15.6%) (Fig. 3; Table 1b). Parenteral antimicrobials accounted for
one-third of all prescribed antimicrobials and they were more likely
to be used in the ED than in the outpatient departments (50.7% vs.
21.4%; P < 0.0001). The common use of more expensive parenteral
antimicrobials also increased antimicrobial-related costs: a total of
$4.64 million was paid on antimicrobials by patients as out-of-
pocket costs. The median out-of-pocket parenteral antimicrobials
cost per prescription was $13, nearly double the median cost of oral
antimicrobials ($7). As co-prescriptions of antimicrobial(s) with other
medications were common, the total out-of-pocket medication costs
Table 1 (continued)
(b)
Characteristic Total [N (%)] Outpatient [n (%)] ED [n (%)]
Penicillins 15 001 (3.5) 12 184 (4.7) 2 817 (1.6)
Amoxicillin 9 457 8 498 959
Penicillin 5 544 3 686 1 858
Imidazoles (metronidazole) 20 710 (4.8) 15 650 (6.1) 5 060 (2.9)
Aminoglycosides 472 (0.1) 420 (0.2) 52 (0.03)
Amikacin 256 239 17
Gentamicin 126 101 25
Tetracycline (minocycline) 384 (0.1) 384 (0.1) 0
All other antimicrobials 13 346 (3.1) 12 815 (5.0) 531 (0.3)
Antimicrobial administration route
Oral 287 168
(66.8)
202 304 (78.6) 84 864 (49.3)
Parenteral 142 453
(33.2)
55 055 (21.4) 87 398 (50.7)
Other 29 (0.01) 29 (0.01) 0
Patients’ out-of-pocket costs for antimicrobials (in 2014 US$)
Sum of all antimicrobial costs 4 644 734 2 790 252 1 854 482
Sum of all oral antimicrobial costs 2 616 978 2 148 955 468 023
Sum of all parenteral antimicrobial costs 2 027 560 641 101 1 386 459
Median (IQR) cost/prescription 9 (5–15) 10 (5–17) 8 (5–14)
Oral antimicrobials cost/prescription 7 (5–12) 9 (5–15) 5 (4–7)
Parenteral antimicrobials cost/prescription 13 (6–19) 11 (4–18) 14 (9–28)
Patients’ total out-of-pocket costs for all medications (in 2014 US$)
Sum of all medication costs 8 716 516 5 337 601 3 378 914
Median (IQR) cost/prescription 19 (12–30) 22 (13–32) 16 (10–28)
Proportion (%) of antimicrobial costs over the total medication costs
Median (IQR) 54 (34–86) 54 (35–82) 55 (34–91)
ED, emergency department; ICD-10, International Classiﬁcation of Diseases, 10th Revision; IQR, interquartile range.
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Fig. 3. Number of top ﬁve antibiotic classes prescribed in 2014 by selected International Classiﬁcation of Diseases Tenth Revision (ICD-10) diagnosis categories.
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Table 2
(a) Characteristics of patients receiving antimicrobial prescriptions by patients’ age group in a large tertiary hospital in Shanghai, China, 2014. (b) Antimicrobial prescribing
patterns by patients’ age group in a large tertiary hospital in Shanghai, China, 2014.
(a)
Characteristic Age group
<5 years [n (%)] 5–17 years [n (%)] 18–49 years [n (%)] 50–64 years [n (%)] ≥65 years [n (%)]
Total antimicrobial-containing prescriptions 67 256 49 474 119 776 72 651 54 485
Patients’ sex
Female 30 293 (45.0) 22 350 (45.2) 64 049 (53.5) 40 833 (56.2) 29 269 (53.7)
Male 36 963 (55.0) 27 124 (54.8) 55 727 (46.5) 31 818 (43.8) 25 216 (46.3)
ICD-10 diagnosis category
Diseases of the respiratory system 39 239 (58.3) 25 707 (52.0) 42 328 (35.3) 23 947 (33.0) 18 002 (33.0)
Acute upper respiratory infection 11 054 8 153 13 028 5 170 2 205
Bronchitis, not speciﬁed as acute or chronic 9 358 3 767 4 428 3 848 3 209
Other respiratory disorders 7 979 5 281 4 888 2 000 1 763
Pneumonia, unspeciﬁed organism 3 078 1 477 3 550 4 955 5 734
Acute tonsillitis 2 991 3 959 3 430 418 65
Acute pharyngitis 238 440 4 431 1 785 598
Other diseases of upper respiratory infection 239 363 4 211 1 496 641
Symptoms, signs and abnormal clinical and laboratory ﬁndings 21 452 (31.9) 15 882 (32.1) 21 014 (17.5) 13 148 (18.1) 10 966 (20.1)
Fever of other and unknown origin 11 499 8 101 7 891 4 226 4 017
Cough 9 195 6 012 2 444 1 372 837
Abdominal and pelvic pain 486 1 304 6 573 3 844 2 329
Diseases of the digestive system 2 865 (4.3) 2 993 (6.0) 21 280 (17.8) 12 032 (16.6) 6 632 (12.2)
Gastritis and duodenitis 1 255 1 432 3 869 2 675 1 041
Non-infective gastroenteritis and colitis 875 729 5 088 1 835 1 008
Diseases of pulp and periapical tissues 16 117 1 524 1 236 585
Diseases of the genitourinary system 287 (0.4) 353 (0.7) 11 620 (9.7) 7 681 (10.6) 5 934 (10.9)
Other disorders of urinary system 262 269 6 023 5 126 3 916
Inﬂammatory diseases of prostate 0 1 1 046 312 77
Calculus of kidney and ureter 0 2 651 518 167
Infectious and parasitic diseases 2 651 (3.9) 2 474 (5.0) 8 066 (6.7) 5 193 (7.1) 2 895 (5.3)
Bacterial infection of unspeciﬁed site 958 1 028 1 935 1 027 304
Infectious gastroenteritis and colitis, unspeciﬁed 932 1 017 1 760 580 286
Zoster 0 15 1 102 1 511 900
Injury, poisoning and other consequences of external causes 104 (0.2) 383 (0.8) 3 970 (3.3) 1 881 (2.6) 1 003 (1.8)
Injury of unspeciﬁed body region 26 151 1 737 779 298
Unspeciﬁed injuries of head 37 74 593 245 247
Diseases of the circulatory system 100 (0.1) 247 (0.5) 1 346 (1.1) 1 575 (2.2) 3 752 (6.9)
Non-speciﬁc lymphadenitis 94 226 816 371 101
Primary hypertension 1 6 198 461 748
Diseases of the ear and mastoid process 380 (0.6) 963 (1.9) 3 419 (2.9) 1 999 (2.8) 845 (1.6)
Suppurative and unspeciﬁed otitis media 348 610 1 248 952 413
Otitis externa 11 209 1 317 591 230
Diseases of the skin and subcutaneous tissue 53 (0.1) 256 (0.5) 2 813 (2.3) 1 824 (2.5) 1 098 (2.0)
Other local infections of skin and subcutaneous tissue 5 35 628 612 426
Cutaneous abscess, furuncle and carbuncle 0 21 446 344 211
Cellulitis and acute lymphangitis 4 78 393 280 121
All other diagnoses 125 (0.2) 216 (0.4) 3 920 (3.3) 3 371 (4.6) 3 358 (6.2)
Dorsalgia 0 15 526 442 194
General examination without complaint 63 61 504 211 94
Unspeciﬁed soft tissue disorders 8 22 362 253 159
(b)
Characteristic Age group
<5 years [n (%)] 5–17 years [n (%)] 18–49 years [n (%)] 50–64 years [n (%)] ≥65 years [n (%)]
Total prescribed antimicrobials 71 115 54 255 148 848 90 286 65 146
Antimicrobial class
Cephalosporins 48 276 (67.9) 38 235 (70.5) 74 091 (49.8) 41 914 (46.4) 32 573 (50.0)
Cefuroxime 18 833 12 905 21 458 13 293 12 017
Cefaclor 19 928 14 587 21 668 10 276 6 591
Cefprozil 164 1 367 15 794 8 904 6 096
Macrolides/lincosamides 20 586 (28.9) 12 226 (22.5) 25 645 (17.2) 13 097 (14.5) 6 152 (9.4)
Azithromycin 10 777 9 298 3 448 1 700 1 019
Clindamycin 176 1 040 14 239 6 795 3 476
Midecamycin 9 626 1 564 9 0 0
Quinolones 0 111 (0.2) 26 983 (18.1) 20 918 (23.2) 18 930 (29.1)
Levoﬂoxacin – 80 23 544 18 912 17 621
Norﬂoxacin – 30 3 184 1 619 906
Moxiﬂoxacin – 1 255 386 401
Penicillins 1 371 (1.9) 2 498 (4.6) 5 118 (3.4) 3 957 (4.4) 2 057 (3.2)
Amoxicillin 401 1 025 4 051 2 773 1 207
Penicillin 970 1 473 1 067 1 184 850
Aminoglycosides 1 11 (0.02) 137 (0.09) 194 (0.2) 129 (0.2)
Tetracyclines (minocycline) 0 13 (0.02) 271 (0.2) 64 (0.07) 36 (0.06)
(continued on next page)
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were about $8.7 million with a median cost per prescription of $19.
Overall antimicrobials accounted for about 50% of total medica-
tions cost (median proportion, 54%), but there was a wide range in
the proportion of antimicrobial costs over the total medication costs.
Age-speciﬁc antimicrobial prescriptions showed different pat-
terns across ﬁve age groups (Table 2a). More female patients received
antimicrobial prescriptions in the adult age groups, reﬂecting pop-
ulation demographics in the catchment area. The results further
supported possible irrational use of antibiotics in all age groups for
diseases or conditions without clear indications of bacterial infec-
tions, such as AURI, bronchitis, pharyngitis, fever or cough, or general
examination without complaint. Regarding age-speciﬁc antibiotic
classes, cephalosporins and macrolides/lincosamides were the most
common antibiotics prescribed to children aged <18 years. However,
111 quinolones, which affect bone development and are not rec-
ommended for use in children, were still prescribed to 95 children
aged 5–17 years. Higher proportions of quinolone-based prescrip-
tions were seen in all three adult age groups, likely due to the
common diagnoses of diseases of the digestive system or abdom-
inal and pelvic pain. Parenteral antimicrobials were more likely to
be prescribed to children or adults aged ≥65 years. The total out-
of-pocket antimicrobial costs and total medication costs were highest
in adults aged 18–49 years ($1.61 million and $2.89 million, re-
spectively), but the median antimicrobial costs and the median all
medication costs per prescription were highest in adults aged ≥65
years, possibly because of the use of parenteral antimicrobials as
well as other co-morbidities.
4. Discussion
In this study using routinely collected hospital pharmacy records
to examine antimicrobial prescription patterns, we found that an-
tibiotics (mainly broad-spectrum) were commonly prescribed to
patients without clear indications of bacterial infections. For in-
stance, more than 100 000 antibiotic prescriptions were for patients
who were diagnosed with AURI, bronchitis, fever or cough. It is also
alarming that antibiotics were even prescribed to some adults who
were diagnosedwith cardiovascular diseases or those seeking general
physical examinations. This result may reﬂect pressure from pa-
tients who insist on antibiotic prescription or a loophole in antibiotic
management under the current healthcare system and needs to be
further addressed by the hospital.
In addition, co-prescription of at least two antimicrobials or with
other medications was common, raising concerns about possible
drug–drug interactions or adverse events associated with multi-
ple drug use, especially for patients with existing liver or kidney
diseases.
Another important ﬁnding from this study is that antibiotics,
including cephalosporins, quinolones and imidazoles, were pre-
scribed to patients with diseases of the digestive system (mainly
adults with gastritis and duodenitis or non-infective gastroenteri-
tis and colitis). In China, patients with diarrhoeal diseases are
commonly treated with antibiotics [18]. It is unlikely that a diag-
nostic test result was obtained to identify pathogenic micro-
organisms among these patients prior to antibiotic prescription,
because only 4575 prescriptions were for infectious gastroenteri-
tis and colitis. Although antibiotics can be used to treat Helicobacter
pylori-associated gastritis and duodenitis, a cephalosporin- or
quinolone-based regimen was not consistent with the current treat-
ment guidelines for H. pylori infection. As many diseases of the
digestive system are caused by viral infections or lifestyle risk
factors, overuse of antibiotics will increase the risk of resistant
infections and cause unexpected harmful consequences, such as
eradication of normal ﬂora and induction of Shiga-toxin phage
[19]. Thus, antibiotic therapy for diseases of the digestive system
must be weighed against risks and beneﬁts.
Antimicrobial-related medical expenditure also presents impor-
tant economic burdens both to patients and the healthcare system
[5]. In Shanghai Tenth People’s Hospital, a total of $4.64 million was
spent as out-of-pocket costs on antimicrobials by patients in 2014,
and more expensive parenteral antimicrobials were also common-
ly used. Considering that many health plans cover a large portion
of the drug cost, the actual spending on antimicrobials would be
much higher. Thus, reducing unnecessary antimicrobial use will
result both in public health and ﬁnancial beneﬁts.
This study demonstrates a practical example of using EHRs to
evaluate the quality of antibiotic use in a large hospital, to provide
feedback to improve rational use of antibiotics, and to help design
appropriate interventions in order to reduce inappropriate antibi-
otic use. In China, whilst antibiotic prescriptions have gradually
declined since the legislation on antibiotic use was implemented,
multiple barriers still exist for rational use of antibiotics
[2–5,11,18,20]. The results from the current study suggest possi-
ble pressure from patients to insist on antibiotics as well as
Table 2 (continued)
(b)
Characteristic Age group
<5 years [n (%)] 5–17 years [n (%)] 18–49 years [n (%)] 50–64 years [n (%)] ≥65 years [n (%)]
Imidazoles (metronidazole) 11 (0.02) 532 (1.0) 11 319 (7.6) 5 921 (6.6) 2 927 (4.5)
All other antimicrobials 870 (1.2) 2 529 (4.7) 6 526 (4.4) 4 659 (5.2) 2 396 (3.7)
Antimicrobial administration route
Oral 44 020 (61.9) 33 817 (62.3) 109 664 (73.7) 62 474 (69.2) 37 193 (57.1)
Parenteral 27 091 (38.1) 20 436 (37.7) 39 181 (26.3) 27 803 (30.8) 27 942 (42.9)
Other 4 2 3 9 11
Patients’ out-of-pocket costs for antimicrobials (in 2014 US$)
Sum of all antimicrobial costs 503 729 503 910 1 608 806 1 127 644 900 644
Sum of oral antimicrobial costs 292 532 275 030 1 000 923 640 016 408 477
Sum of parenteral antimicrobial costs 211 165 228 865 607 873 487 586 492 070
Median (IQR) cost/prescription 7 (5–9) 9 (5–14) 9 (5–18) 10 (5–19) 11 (6–23)
Oral antimicrobial costs 6 (5–7) 7 (5–11) 6 (5–12) 7 (5–15) 9 (5–17)
Parenteral antimicrobial costs 9 (5–9) 14 (9–14) 13 (4–28) 17 (4–29) 14 (10–29)
Patients’ total out-of-pocket costs for all medications (in 2014 US$)
Sum of all medication costs 1 100 222 1 026 169 2 890 852 2 041 813 1 657 459
Median (IQR) cost/prescription 15 (11–21) 20 (14–26) 19 (11–32) 24 (13–37) 25 (13–41)
Proportion (%) of antimicrobial costs over total medication costs
Median (IQR) 49 (33–66) 51 (34–71) 56 (35–94) 58 (35–95) 61 (35–96)
IQR, interquartile range.
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physicians’ lack of knowledge about rational antibiotic use. Thus,
to design effective interventions to improve antibiotic prescrip-
tions, it is essential to understand characteristics of the patient
populations and obstacles for antibiotic prescription from physi-
cians’ or hospitals’ perspectives.
As this was an exploratory study, several important study limi-
tations need to be discussed when interpreting the ﬁndings. First,
due to technical diﬃculties, only antimicrobial-containing phar-
macy records were obtained, not all outpatient visits and pharmacy
records; thus, we were unable to use someWHO-recommended in-
dicators such as DDDs or antibiotic prescription rates to assess
appropriate antimicrobial use [15]. Second, because only one primary
diagnosis, which was determined by the physician based on a pa-
tient’s chief complaint, was documented on the pharmacy records,
it was not clear whether patients could present with other dis-
eases or conditions thatmight be suitable for antimicrobial use. Thus,
the magnitude of irrational antibiotic use might be overesti-
mated. It is our ongoing effort to evaluate antibiotic prescriptions
and to educate physicians to improve the quality of antibiotic pre-
scriptions. Third, we were unable to link the pharmacy records with
patients’ medical records or laboratory results in order to evalu-
ate whether any diagnostic test(s) had been performed prior to
antimicrobial prescription. Finally, since this is a single-centre study
conducted in a large tertiary hospital, the results may not be
generalisable to other healthcare facilities. Despite these limita-
tions, this study still provides important new information on
antimicrobial use patterns and is also a good example of using large
data sets to identify gaps in antimicrobial management.
5. Conclusions
In conclusion, 10 years after the Ministry of Health of the Pe-
ople’s Republic of China released the ‘Principles of clinical use of
antibiotics’, unnecessary antibiotic use is still common in real-
world clinical practice and remains a public health challenge. This
study shows that routine assessment using EHRs is a useful tool to
evaluate antibiotic prescription patterns, to identify possible irra-
tional use of antibiotics, and to provide feedback to improve the
quality of antibiotics use. Antibiotic use for patients with diseases
of the digestive system needs to be further investigated.
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